उत्पाद विवरण
Degapride 120 mg injection is a targeted anti-cancer treatment specifically designed for managing prostate cancer, a condition that arises in the prostate gland responsible for producing seminal fluid in men. This medication functions by lowering testosterone levels, a hormone that can fuel the growth of prostate cancer cells, thereby potentially hindering or halting their progression. Patients receiving Degapride should be monitored for potential side effects, including hormonal changes and reactions at the injection site. It is crucial for individuals to discuss their medical history with a healthcare provider prior to starting this therapy, as certain pre-existing conditions may influence treatment outcomes. The injection is typically administered under the guidance of a medical professional to ensure optimal dosing and effectiveness. With careful management, Degapride 120 mg can play a significant role in the comprehensive treatment plan for prostate cancer. Always consult a qualified healthcare provider for personalized advice and to understand the benefits and risks associated with this medication.